A Randomised, Double-blind, Placebo-controlled, Multi-centre, Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Chinese Asthmatic Patients Allergic to House-dust Mites

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
A phase III study to assess the efficacy and safety of sublingual immunotherapy with STALORAL dust mites solution compared with placebo for reduction of asthma symptoms.
Epistemonikos ID: 2e488d3916002b5f2f746bd24bc830e5b76a2f79
First added on: May 05, 2024